JANX
NASDAQ · Biotechnology
Janux Therapeutics Inc
$14.99
+0.08 (+0.54%)
Open$14.82
Previous Close$14.91
Day High$15.07
Day Low$14.79
52W High$35.34
52W Low$12.12
Volume—
Avg Volume881.3K
Market Cap867.20M
P/E Ratio—
EPS$-1.84
SectorBiotechnology
Analyst Ratings
Strong Buy
26 analysts
Price Target
+227.6% upside
Current
$14.99
$14.99
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.84M | 9.36M | 135.69M |
| Net Income | -111,820,922 | -95,737,090 | 14.63M |
| Profit Margin | -1,136.3% | -1,079.4% | 10.8% |
| EBITDA | -153,168,318 | -138,422,661 | 20.57M |
| Free Cash Flow | — | — | 20.68M |
| Rev Growth | +5.1% | +5.1% | +1.9% |
| Debt/Equity | — | — | 0.42 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |